Avalon GloboCare’s Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary

Rhea-AI Summary

Avalon GloboCare (NASDAQ: ALBT) said subsidiary Avalon Quantum AI filed a U.S. provisional patent application (No. 63/961,889) on Jan 16, 2026 for “Systems and Methods for Evidence-Constrained, Audience-Adaptive Generation of Automated Commentary Videos.”

The filing describes an AI architecture that enforces evidence-linked generation, builds structured evidence graphs, detects source contradictions, applies uncertainty handling, and embeds traceability and audit metadata into video outputs to support editorial review, compliance validation, and accountability.

Positive

• Provisional patent filed on Jan 16, 2026 (No. 63/961,889)
• Targets regulated content markets such as financial commentary and news

Negative

• Application is provisional only; no patent grant or claims yet
• No commercial agreements, revenue, or monetization terms disclosed

News Market Reaction

+1.63%

3 alerts

+1.63% News Effect

+12.2% Peak Tracked

+$61K Valuation Impact

$4M Market Cap

0.4x Rel. Volume

On the day this news was published, ALBT gained 1.63%, reflecting a mild positive market reaction. Argus tracked a peak move of +12.2% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $61K to the company's valuation, bringing the market cap to $4M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Patent application number: 63/961,889

1 metrics

Patent application number 63/961,889 U.S. provisional patent application for AI video commentary, filed Jan 16, 2026

Market Reality Check

Price: $0.8299 Vol: Volume 572,806 is about 1...

normal vol

$0.8299 Last Close

Volume Volume 572,806 is about 1.32x the 20-day average of 433,269 ahead of this AI patent news. normal

Technical Shares at 0.8775 trade below the 200-day MA of 2.45, well off the 11.66 52-week high.

Peers on Argus

ALBT’s -20.23% pre-news decline contrasts with mixed peers: LRHC -2.19%, WETH -0...

1 Down

ALBT’s -20.23% pre-news decline contrasts with mixed peers: LRHC -2.19%, WETH -0.56%, GBR +0.55%, DUO +1.32%, CHG flat, pointing to a stock-specific move.

Historical Context

5 past events · Latest: Jan 20 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 20	Product/regulatory update	Positive	-6.0%	KetoAir FDA registration renewal and planned AI-driven B2B/B2C launch.
Jan 12	Listing compliance, AI	Positive	-10.2%	Nasdaq equity compliance regained and AI video platform marketing plans.
Dec 30	AI platform highlight	Positive	-6.0%	Showcasing RPM’s Catch-Up generative AI video SaaS in media interview.
Dec 15	AI acquisition deal	Positive	-24.6%	All-stock acquisition of RPM Interactive via Avalon Quantum AI subsidiary.
Dec 01	Operational progress	Positive	-8.1%	KetoAir Q3 progress, UK launch, and Nevada first-responder program update.

Pattern Detected

Positive corporate developments have repeatedly coincided with negative next-day price reactions, suggesting a pattern of selling into news.

Recent Company History

Over the last several months, Avalon GloboCare has focused on KetoAir™ commercialization and generative AI video infrastructure. On Dec 15, 2025, it acquired RPM Interactive via an all-stock deal, followed by highlighting the Catch-Up AI video platform on Dec 30, 2025. Subsequent AI-tagged updates on Nasdaq compliance and KetoAir FDA registration renewal in Jan 2026 all saw negative 24-hour price moves. Today’s AI patent filing extends the same Avalon Quantum AI and automated video commentary strategy.

Market Pulse Summary

This announcement details a U.S. provisional patent for evidence-constrained generative AI systems a...

Analysis

This announcement details a U.S. provisional patent for evidence-constrained generative AI systems aimed at compliance-ready automated video commentary. It extends Avalon’s recent AI initiatives through Avalon Quantum AI and the Catch-Up™ platform. Historically, news on Nasdaq compliance, RPM Interactive acquisition, and KetoAir™ expansion all shaped the same narrative of shifting toward AI-enabled consumer and media products. Investors may track how this patent integrates into existing SaaS offerings and whether it supports future enterprise adoption.

Key Terms

provisional patent application, generative ai, source traceability, auditability, +4 more

8 terms

provisional patent application regulatory

"Avalon Quantum AI LLC, has filed a U.S. provisional patent application covering"

A provisional patent application is a lightweight, temporary filing that records an inventor’s idea and sets an official filing date without starting the full patent review process. Think of it as placing a hold on an idea while you prepare the complete paperwork; it doesn’t grant a patent but can preserve the right to seek one later. For investors, it signals a company is protecting potential intellectual property, which can affect future competitive advantage and valuation, but it is not a guarantee of patent protection.

generative ai technical

"evidence-constrained generative AI systems designed to produce automated video commentary"

Generative AI is a type of computer technology that can create new content, like text, images, or music, on its own. It’s important because it can produce realistic and useful material quickly, which could change how we create art, write stories, or even develop new products. Think of it as a smart robot that can invent and produce things almost like a human.

source traceability technical

"video commentary with built-in source traceability and auditability"

The ability to follow and verify the origin and history of a piece of information, data, product or biological sample through documented links from its source to its current state. For investors, strong source traceability means higher confidence in claims, regulatory compliance and lower risk of fraud or recalls—like being able to open a package and see every stop it took, which makes the asset or data more trustworthy and easier to audit.

auditability technical

"video commentary with built-in source traceability and auditability"

Auditability is how easily a company’s records, systems and transactions can be checked and verified by independent reviewers. Like a recipe with clear steps and labeled ingredients that anyone can follow to reproduce the dish, strong auditability helps investors trust that reported results are accurate, reduces the risk of hidden problems or fraud, and makes regulatory and financial reviews faster and more reliable.

evidence-constrained technical

"new class of evidence-constrained generative AI systems designed to produce"

Evidence-constrained describes a decision, claim or regulatory assessment that is limited by the amount, quality or completeness of available data, meaning conclusions are provisional because the supporting evidence is thin or uncertain. For investors it matters because these limits increase the chance of later revisions, regulatory delays or unexpected risks — like buying a product with a partially blurred instruction manual, you must allow for greater uncertainty and tighter risk management.

evidence graphs technical

"The system constructs structured evidence graphs from input media"

Evidence graphs are visual maps that show how pieces of data, studies, documents and statements connect to support a particular claim or conclusion. For investors they act like a roadmap that reveals where a claim comes from, how strong the links are, and whether key supporting items are missing or weak — similar to checking a plumber’s receipts and photos before trusting their work. Clear evidence graphs help spot overstated claims, reduce surprise risk, and improve decision-making.

uncertainty handling technical

"applies uncertainty handling logic to generate balanced or qualified commentary"

Processes, policies and tools a company uses to identify, assess and respond to unknowns that could affect its operations, finances or strategy. For investors, strong uncertainty handling is like a pilot preparing for changing weather: it reduces the chance of surprises, makes forecasts more reliable and can protect value when markets or regulations shift, while weak practices increase the risk of sudden losses or missed opportunities.

hallucination risk technical

"Our technology has the potential to reduce hallucination risk while enabling"

Hallucination risk is the chance that automated or AI-generated content produces false, misleading, or invented facts presented as true. Like a GPS that invents roads and steers you wrong, these errors can mislead investors about a company’s financials, regulatory status, clinical results, or other market-moving details, leading to bad investment choices, price swings, or the need for costly corrections — so verification of sources matters.

AI-generated analysis. Not financial advice.

Provisional Patent Application Covers Systems and Methods for Evidence-Constrained, Audience-Adaptive Generation of Automated Commentary Videos

FREEHOLD, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that its subsidiary, Avalon Quantum AI LLC, has filed a U.S. provisional patent application covering a new class of evidence-constrained generative AI systems designed to produce automated video commentary with built-in source traceability and auditability.

The provisional patent application, titled “Systems and Methods for Evidence-Constrained, Audience-Adaptive Generation of Automated Commentary Videos” (U.S. Provisional Patent Application No. 63/961,889), was filed on January 16, 2026. The filing describes a proprietary AI architecture intended to address a structural risks in generative media markets: the inability to reliably verify, audit, and defend AI-generated outputs at scale.

Unlike conventional generative video systems, the disclosed technology enforces an evidence-linked generation framework in which every narrative assertion within a rendered video must be explicitly supported by underlying source materials. The system constructs structured evidence graphs from input media, governs script generation through evidence constraints, detects contradictions across sources, and applies uncertainty handling logic to generate balanced or qualified commentary when conflicts arise. Traceability and audit metadata are embedded directly into the final video output, enabling downstream editorial review, compliance validation, and accountability.

“We believe our technology has the potential to reduce hallucination risk while enabling scalable automation in high-value, highly regulated content markets, including financial commentary, news, sports analysis, and brand-sensitive media,” said Meng Li, Avalon’s Interim Chief Executive Officer and Chief Operating Officer. “As AI-generated media becomes increasingly regulated, scrutinized, and monetized, the ability to prove what information was used, where it came from, and how it was presented is rapidly becoming a competitive necessity. This provisional filing reflects our strategy to build AI media infrastructure that is not only scalable and automated, but also verifiable, defensible, and enterprise-ready.”

About Avalon GloboCare Corp.

Avalon GloboCare Corp. (NASDAQ: ALBT) is a diversified company focused on the development of precision diagnostic consumer products, the advancement of intellectual property in cellular therapy, and generative artificial intelligence publishing and software. Avalon is currently marketing the KetoAir™ breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir^TM is registered with the U.S. Food and Drug Administration as a Class I medical device. The Company also continues to focus on advancing its intellectual property portfolio through existing patent applications. In addition, Avalon owns and operates commercial real estate.

For more information about Avalon, please visit www.avalon-globocare.com. Information on the Company’s website does not constitute a part of and is not incorporated by reference into this press release.

Forward-Looking Statements

Certain statements contained in this press release are “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve several risks and uncertainties. You can identify these statements by the fact that they use words such as “will”, “anticipate”, “estimate”, “expect”, “should”, “may”, and other words and terms of similar meaning or use of future dates; however, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, including statements regarding the ability to enter into a definitive agreement, as well as the Company’s commercialization, distribution and sales of its products and the product’s ability to compete with other similar products. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the SEC, accessible through the SEC’s website (http://www.sec.gov), including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed or furnished with the SEC. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. The Company disclaims any obligation to update forward-looking statements. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release. The contents of any website referenced in this press release are not incorporated by reference herein.

Contact Information:
Avalon GloboCare Corp.
4400 Route 9 South, Suite 3100
Freehold, NJ 07728
PR@Avalon-GloboCare.com

Investor Relations:
Crescendo Communications, LLC
Tel: (212) 671-1020 Ext. 304
albt@crescendo-ir.com

FAQ

What did Avalon GloboCare announce about AI patent filing for ALBT on Jan 22, 2026?

Avalon said subsidiary Avalon Quantum AI filed a U.S. provisional patent (No. 63/961,889) on Jan 16, 2026 for evidence-constrained automated commentary videos.

What does Avalon’s provisional patent (ALBT) cover?

The filing covers systems and methods for evidence-linked generative AI that builds evidence graphs, detects contradictions, and embeds traceability metadata.

How might the ALBT patent filing affect Avalon’s addressable markets?

The company targets high-value regulated markets including financial commentary, news, sports analysis, and brand-sensitive media.

Does Avalon’s Jan 16, 2026 provisional patent give immediate enforceable rights for ALBT shareholders?

No; a provisional filing secures a filing date but does not provide an issued patent or enforceable patent rights.

What problems does Avalon claim its AI architecture aims to solve for ALBT?

It aims to reduce hallucination risk by enforcing evidence constraints, source traceability, and auditability in generated videos.

Where can investors find the provisional application details for ALBT?

The announcement lists the U.S. provisional patent application number 63/961,889 and the filing date Jan 16, 2026.